BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36083003)

  • 1. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
    Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
    J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome.
    Mathieson L; Koppensteiner L; Dorward DA; O'Connor RA; Akram AR
    Br J Cancer; 2024 May; 130(11):1758-1769. PubMed ID: 38582812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
    Kilvaer TK; Rakaee M; Hellevik T; Østman A; Strell C; Bremnes RM; Busund LT; Dønnem T; Martinez-Zubiaurre I
    PLoS One; 2018; 13(2):e0192157. PubMed ID: 29415055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY; Yeo SY; Xuan YH; Kim SH
    PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis.
    Zhao Y; Jia Y; Wang J; Chen X; Han J; Zhen S; Yin S; Lv W; Yu F; Wang J; Xu F; Zhao X; Liu L
    Mol Cancer; 2024 Mar; 23(1):47. PubMed ID: 38459511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
    Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
    Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
    Kilvaer TK; Khanehkenari MR; Hellevik T; Al-Saad S; Paulsen EE; Bremnes RM; Busund LT; Donnem T; Martinez IZ
    PLoS One; 2015; 10(8):e0134965. PubMed ID: 26252379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
    Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
    Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinoma.
    Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    Thorac Cancer; 2022 Aug; 13(16):2377-2384. PubMed ID: 35818720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
    Huang WC; Yadav VK; Cheng WH; Wang CH; Hsieh MS; Huang TY; Lin SF; Yeh CT; Kuo KT
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer.
    Venning FA; Zornhagen KW; Wullkopf L; Sjölund J; Rodriguez-Cupello C; Kjellman P; Morsing M; Hajkarim MC; Won KJ; Erler JT; Madsen CD
    J Exp Clin Cancer Res; 2021 May; 40(1):175. PubMed ID: 34016130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
    Li M; Li G; Kiyokawa J; Tirmizi Z; Richardson LG; Ning J; Das S; Martuza RL; Stemmer-Rachamimov A; Rabkin SD; Wakimoto H
    Acta Neuropathol Commun; 2020 Dec; 8(1):221. PubMed ID: 33308315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.
    McAndrews KM; Chen Y; Darpolor JK; Zheng X; Yang S; Carstens JL; Li B; Wang H; Miyake T; Correa de Sampaio P; Kirtley ML; Natale M; Wu CC; Sugimoto H; LeBleu VS; Kalluri R
    Cancer Discov; 2022 Jun; 12(6):1580-1597. PubMed ID: 35348629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
    Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
    J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of cancer-associated fibroblasts in human cancer.
    Paulsson J; Micke P
    Semin Cancer Biol; 2014 Apr; 25():61-8. PubMed ID: 24560651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic Heterogeneity of Cancer Associated Fibroblasts in Cervical Cancer Progression: FAP as a Central Activation Marker.
    Bueno-Urquiza LJ; Godínez-Rubí M; Villegas-Pineda JC; Vega-Magaña AN; Jave-Suárez LF; Puebla-Mora AG; Aguirre-Sandoval GE; Martínez-Silva MG; Ramírez-de-Arellano A; Pereira-Suárez AL
    Cells; 2024 Mar; 13(7):. PubMed ID: 38606999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts in the tumor microenvironment of tongue carcinoma is a heterogeneous cell population.
    Vered M; Shnaiderman-Shapiro A; Zlotogorski-Hurvitz A; Salo T; Yahalom R
    Acta Histochem; 2019 Nov; 121(8):151446. PubMed ID: 31604589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma.
    Wong PF; Wei W; Gupta S; Smithy JW; Zelterman D; Kluger HM; Rimm DL
    J Immunother Cancer; 2019 Jul; 7(1):194. PubMed ID: 31337426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.